Vincristine Sulfate

High Grade B-Cell Lymphoma

National Cancer Institute (NCI)Small moleculePhase 2/3Active

BB

70/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 60/ 100
Competitive Position: 89/ 100

Competitive context

84 Active assets in the High Grade B-Cell Lymphoma cohort.

Asset / Sponsor	Phase	Rating
Etoposide University of Washington	Phase 3	BB
Isocyclophosphamide University of California, Davis	Phase 3	BB
Prednisone National Cancer Institute (NCI)	Phase 3	BB
Adriamycin National Cancer Institute (NCI)	Phase 3	BB
Axicabtagene Ciloleucel AIDS Malignancy Consortium	Phase 2	BB

View all 50 →

Same molecule, other indications

Vincristine Sulfate is also rated in:

B-cell childhood acute lymphoblastic leukemiaDormant

A

Indicative · Phase 3

81 / 100

diffuse large B-cell lymphomaActive

A

Indicative · Phase 2/3

80 / 100

childhood acute lymphoblastic leukemiaDormant

BBB

Indicative · Phase 3

76 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.